Luteolin reduces cytarabine-resistant acute myeloid leukemia cell proliferation through the GSK3β/Nrf2 pathway
Year: 2026
Type: article
Source: Cytotechnology
Institution: Kunming Children's Hospital
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225320103
